This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AAPL BBY MSFT VZ NOK

ServiceNow (NOW) rated new outperform at JMP Securities. $56 price target. Company is a cloud leader in IT Service Management.

Pharmacyclics (PCYC) upgraded at Lazard to buy, Lazard Capital Markets said. $141 price target. Checks show a strong outlook for ibrutinib.

Rowan (RDC) upgraded at JP Morgan from neutral to overweight, JP Morgan said. Dayrates have likely bottomed. $39 price target.

Select Medical (SEM) downgraded at Wells from market perform to underperform, Wells Fargo said. Long-term acute care hospitals will face Medicare reimbursement risks in 2015.

Vivus (VVUS) downgraded at Lazard to sell, Lazard Capital Markets said. $8 price target. Qsymia has had a slow launch and the company's patents could face competition.

Verizon (VZ - Get Report) upgraded at Baird from neutral to outperform, Robert Baird said. $53 price target. VZW purchase should benefit long-term positioning and earnings growth.

STOCK COMMENTS / EPS CHANGES

Abbott Laboratories (ABT) numbers lowered at Jefferies. Shares of ABT now seen reaching $44, Jefferies said. Estimates also lowered on model adjustment. Buy rating.

eBay (EBAY) added to Best Ideas List at Wedbush. EBAY was placed on the Best Ideas list, according to Wedbush. Paypal is winning and marketplace growth is reaccelerating. Outperform rating and $64 price target.

Halliburton (HAL) estimates, target raised at Sterne Agee. Shares of HAL now seen reaching $63, according to Sterne Agee. Estimates also increased, following the company's dutch auction repurchase. Buy rating.

Microsoft (MSFT - Get Report) estimates, target reduced at BMO. Shares of MSFT now seen reaching $35, according to BMO Capital. Estimates also cut, as the Nokia deal will cut into earnings.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AAPL $131.78 -0.20%
BBY $34.18 -0.52%
NOK $7.38 0.41%
MSFT $47.45 -0.34%
VZ $49.54 -0.06%

Markets

DOW 18,126.12 -36.87 -0.20%
S&P 500 2,120.79 -2.69 -0.13%
NASDAQ 5,097.9760 -8.6170 -0.17%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs